Asian Phytocuticals Public Company Limited, or APCO, has launched a new product, BIM AD, for brain health care, building on its knowledge of immunotherapy from mangosteen extract to expand its portfolio in the Brain Health segment and tap the Preventive Wellness market, in line with the growing trend of consumers placing greater emphasis on preventive health care. Professor Dr. Picheth Viriyachitra, Chief Executive Officer, said BIM AD was developed by extending stem cell knowledge combined with immunotherapy innovation from mangosteen extract, through the concept of stimulating stem cells involved in the body's tissue creation and repair processes, aiming to support brain health care and long-term internal organ recovery. The company plans to publish the research on this innovation in an international academic journal within October. As for its marketing plan, the company will focus mainly on the domestic market, targeting consumers aged 40 and above, and using the BIM Advisor model as a channel to expand its customer base, alongside providing accurate knowledge and information about health care. This is expected to help broaden its customer base in the Brain Health segment and drive sales growth in the second half of this year.
Asian Phytoceuticals Public Company LimitedAPCO launched BIM AD, a new brain-health product built on its mangosteen-extract immunotherapy innovation, expanding its portfolio.
